← Back to NNNN Overview
Anbio Biotechnology Class A Ordinary Shares (NNNN)
Profitability & Net Margin History
Current Net Margin
82.84%
Anbio Biotechnology Class A Ordinary Shares currently has a net profit margin of 82.84%. Net margin is a key efficiency ratio that measures what percentage of each dollar of revenue actually results in profit for the company.
Historical Margin Data
Quarterly and annual profitability trends
| Date | Revenue ($B) | Net Income ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-06-30 | 0.01 | 0.00 | 82.84% | ▲13524 |
| 2024-12-31 | 0.00 | -0.00 | -52.40% | ▼11388 |
| 2024-06-30 | 0.01 | 0.00 | 61.48% | ▲4141 |
| 2023-12-31 | 0.00 | 0.00 | 20.07% | ▼2963 |
| 2023-06-30 | 0.00 | 0.00 | 49.70% | — |
* Net margin = (Net Income / Total Revenue) * 100. Based on official SEC filings.